Compliance & EnforcementExpert Opinion
ArchiveExpert Opinion
8,107 articles from the Compliance & Enforcement Brief.
Articles
🔒 Members Only · Compliance & Enforcement BriefYou’ve reached the member portion of this brief.Members read the full analysis and the source documents in every Brief, six days a week.
COVID-19: What History Tells Us About the Importance of the False Claims Act in a Time of Pandemic
$4.47 Million False Claims Act Settlement Targets Set-Aside Contractors, Affiliates, and Even Third-Party Bonding Company
Update: Investigations Under the CARES Act Ramp Up Even as Oversight Roles Remain Vacant
U.S. Paycheck Protection Program Loan Recipients: Risks of Qui Tam Actions Under the False Claims Act
Mitigating Bribery and FCPA Risks in the Time of COVID-19
The PPP Litigation Wave Is Coming: Anticipated “Qui Tam” Lawsuits Under the False Claims Act
The Value of the Whistleblower Program
Purchasing a Rolls-Royce Is Not a Permissible Use of PPP Funds
12 Steps for Reducing CARES Act Enforcement Risks
Cancer Treatment Center Agrees to DPA and $100 Million Penalty for Criminal Antitrust Violations in Florida Market
Top 10 International Anti-Corruption Developments for April 2020
False Claims Act Exposure for Beneficiaries of the Public Health and Social Services Emergency Relief Fund: Mitigating Risks of Ambiguous Terms & Conditions
Clinical Laboratory to Pay $43 Million to Resolve FCA Liability for Medically Unnecessary Tests; Settlement Demonstrates Importance of Addressing Employee Compliance Concerns
California False Claims Expansion Bill Preparing to Advance
Qui Tam Complaint Against Pharmacy Dismissed for Lack of Particularity
Enforcement Agencies Grant Temporary Trade Sanctions and ITAR Compliance Relief Due to COVID-19
Latest SEC FCPA Complaint Vulnerable to Dismissal
DOJ Brings First Payroll Protection Program-Related Criminal Case
Rear View Mirror: Criminal Exposure for Companies that Received PPP Loans Under the CARES Act
Keep reading
